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Among three endothelin (ET) isopeptides, ET-3 shows the most potent initial depressor response through the endothelium-dependent m chanism. 
We studied the presence of specific binding sites for ET-3 in cultured bovine endothelial cells (EC) and its cellular mechanism of action. Binding 
studies revealed the presence of two distinct subclasses of ET-3 receptors with high and low affinities. ET-3 dose-dependently (10 -1° 10 -7 M) 
increased both intracellular Ca z+ levels ([Ca2+]0 and inositol trisphosphate (IP3) formation. The ET-3-induced increase in [Ca2+]i was not affected 
by either emoval of extracellular Ca 2+ or CaZ+-channel blockers. These data suggest that ET-3 induces phosphoinositide br akdown and increase 
in [Ca2+]i in ECs, possibly resulting from intracellular Ca z+ mobilization, thereby leading to vasodilatation. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Endothelin (ET) is a novel potent vasoconstrictor 
peptide with 21 amino acid residues, originally 
characterized from the supernatant of cultured porcine 
endothelial cells (EC) [1]. Recently, three distinct ET 
genes have been demonstrated in the human, porcine 
and rat genomes [2], and cloning and sequence analysis 
of these genes revealed three ET isopeptides (ET-1, 
ET-2, ET-3). ET-1 is identical to human/porcine ET 
and ET-2 is [Trp6,Leu7]ET-1, while ET-3 is identical to 
ET originally deduced from cDNA cloning of rat 
genome. These three isopeptides how different phar- 
macological profiles of pressor/vasoconstrictor ac-
tivities [2]; ET-3, despite its least potency in pressor 
response, exerts the most potent initial depressor 
response among three ET isopeptides. 
Warner et al. have recently demonstrated that ET-3 
is more selective than ET-1 as a vasodilator through the 
release of EDRF at doses 100-fold lower than those re- 
quired to induce vasoconstriction [3], suggesting its 
physiologcal role as a vasodilator rather than a 
vasoconstrictor. To our knowledge, there has been no 
direct evidence that ET-3 directly acts on EC. 
Therefore, the present study was designed to investigate 
whether there exists a specific receptor for ET-3 in 
cultured bovine EC and to elucidate its intracellular 
responses. 
2.1. Binding experiments 
Subcultured bovine carotid artery ECs (7-9th passage) were used 
in the experiments. Binding studies were performed essentially in the 
same manner as [~zSI]ET-1 binding to vascular smooth muscle cells 
(VSMC) as described [4]. Briefly, confluent ECs (-6 × 105 cells) were 
incubated with 2.5 × 10 -13 M [125I]ET-3 (spec. act. -74 TBq/mmol, 
Amersham Japan, Tokyo) in 1 ml Hanks' balanced salt solution con- 
taining 0.1070 bovine serum albumin at 37°C for 60 rain. After com- 
pletion, cells were extensively washed and the cell-bound 
radioactivity was determined. Specific binding was defined as total 
binding minus nonspecific binding in the presence of an excess 
(10 -7 M) of unlabeled ET-3 (Peptide Institute Inc., Osaka, Japan). 
2.2. Measurement of cytosolic free Ca ;+ concentration ([Ca;+]i) 
After incubation in serum-free Dulbecco's modified Eagle's 
medium (DMEM) for 36 h, ECs were trypsinized and incubated with 
4/~M fura-2 acetoxymethyl ester (Dojin Chemicals, Kumamoto, 
Japan) at 37°C for 20 min in Hepes-buffered physiological salt solu- 
tion essentially in the same way as reported [4]. The fluorescence of
CaZ+-fura-2 of the suspended cells (-5 × 106 cells/ml) was measured 
by a spectrofluorimeter (CAF-100; Jasco Co., Ltd., Tokyo, Japan) 
using excitation of 340 and 380 nm, and emission of 500 nm. Values 
of [Ca2+]i were calculated according to the method of Grykiewicz et 
al. [5]. 
2.3. Measurement of inositol-l,4,5-trisphosphate (IP3) 
Confluent ECs preincubated in serum-free DMEM were incubated 
at 37°C with or without ET-3 in Hanks' medium containing 10 mM 
LiC1 for the indicated times. Incubation was terminated by rapid 
removal of medium and addition of ice-cold 15070 trichloroacetic a id 
(TCA), and the cells were placed on ice for 30 min. TCA extract was 
washed with ethylether and neutralized with 1 N sodium acetate. IP3 
levels were determined by a competitive protein binding assay kit 
(Amersham Japan, Tokyo). 
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3. RESULTS 
Specific binding of [t25I]ET-3 to bovine EC was a 
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Fig. 1. Competitive binding of [a25I]ET-3 by unlabeled ET-3 and 
ET-1 to cultured bovine EC. Confluent cells were incubated at 37°C 
for 60 min with 2.5 x 10 ~3 M [125I]ET-3 in the absence and the 
presence of unlabeled ET-3 (e) or ET-1 (©) in concentrations as 
indicated. The bound [~25I]ET-3 was 1.8 fmol/106 cells in the absence 
of unlabeled ET-3. Nonspecific binding was 38% of total binding and 
subtracted from all values. Each point is the mean of two 
experiments. (Inset) Scatchard plot of binding data. 
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Fig. 3. Effect of ET-3 on IP3 formation in cultured bovine EC as a 
function of time. Confluent cells were incubated with ET-3 (10 -7 M) 
in Hanks'  medium containing 10 mM LiCI for the indicated times. 
Each point is the mean of triplicate dishes; bars show SE. Asterisks 
show statistically significant differences from the unstimulated 
control cells (P < 0.05). 
time- and temperature-dependent process; binding at 
37°C was more rapid and greater than at 4°C, reaching 
an equilibrium after 60 min. Nonspecific binding at 
37°C was -40% of total binding throughout he in- 
cubation. As shown in Fig. 1, unlabeled ET-3 com- 
petitively inhibited the binding of [125I]ET-3 to bovine 
EC, whereas ET-1 did not affect the binding in concen- 
trations up to 10 -7 M. Scatchard analysis of the bin- 
ding data (Fig. 1, inset) suggested the presence of two 
distinct subclasses of binding sites for ET-3: one with 
high-affinity (Kd: 6.6 × 10 -~z M) and low capacity 
(Bmax" 50 sites/cell), and the other with low-affinity 
(Kd: 2.5 × 10 -x° M) and high-capacity (Bmax: 490 
sites/cell). 
As shown in Fig. 2, ET-3 dose-dependently 
(10-~o_ 10-7 M) induced an immediate and transient in- 
crease in [Ca2+]i; [CaZ+]i increased significantly (P < 
0.01) from 88 + 2.4 nM (mean + SE, n = 12) to 101 +_ 
1.3 (n = 3, 10 -t° M), 127 +_ 2.3 (n = 3, 10 -9 M), 171 + 
3.5 (n = 3, 10 -8 M) and 219 + 3.0 (n = 3, 10 -7 M) 5 s 
after the addition of ET-3. The increase in  [Ca2+]i 
stimulated by 10-7M ET-3 was not affected by 
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2+ Fig. 2. Changes of Ca -fura-2 fluorescence by ET-3 and ET-1 in cultured bovine EC. Cell suspensions loaded with fura-2 were challenged with 
various doses (10-1°-10 _7 M) of ET-3 and ET-I (10 -7 M). The basal [Ca2+]i were 88 _+ 2.4 nM (mean _+ SE, n = 12). Each panel shows a typical 
tracing from representative experiments. Calculated values for [Ca2+h are shown on the ordinates. 
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pretreatment with either 10 -5 M nicardipine or 3 mM 
EGTA. However, ET-1 (10 -7 M) had no effect. 
ET-3 (10 -7 M) induced an immediate (15-30 s) for- 
mation of IP3, followed by a gradual decline by one 
min (Fig. 3). ET-3 dose-dependently (10-9-10 -7 M) 
stimulated formation of IP3 during 30 s incubation, 
whereas ET-1 (10 -7 M) was without effect (not shown). 
4. DISCUSSION 
It has originally been reported that ET-1 causes a 
transient decrease in systemic arterial blood pressure 
accompanied by regional vasodilating responses in 
anesthetized rats [1,2]. Furthermore, De Nucci et al. 
have reported that ET-1 induces transient depressor 
response in isolated perfused rat mesenteries mediated 
by the release of EDRF [6]. A subsequent s udy by the 
same group has shown that ET-3 is far more potent 
than ET-1 in vasodilating perfused rat mesenteries [3], 
suggesting that ET-3 functions as a vasodilator rather 
than a vasoconstrictor. 
This is the first report demonstrating the presence of 
specific receptors for ET-3 in cultured bovine EC, with 
which ET-1 does not interact. The present binding 
study clearly shows two distinct subpopulations of bin- 
ding sites for ET-3 with higher (Kd: 7 × 10 -12 M) and 
lower (Ka: 2.5 × 10 -l° M) affinities in cultured bovine 
EC. Recent studies have reported that at least two sub- 
types of binding sites for ET isopeptides exist in the 
membranes of chick heart [7] and rat lung [8]; one sub- 
type with preferential binding affinity to ET-1 and 
ET-2, and the other to ET-3, suggesting that the 
population of ET receptor subtypes may differ from 
one tissue to another. Our data indicate that ECs ex- 
press predominantly ET-3 receptor subtype. 
The present study also demonstrates that ET-3, but 
not ET-1, dose-dependently (10-1°-10 -7 M) induces 
profound increases in [Ca2+]i in fura-2-1oaded EC. 
These data are compatible with those of the 
ET-l-induced [Ca2+]i increase in cultured rat VSMC 
[4]. However, the failure of chelating extracellular 
Ca 2+ by EGTA and inhibiting voltage-dependent 
Ca2+-channels by nicardipine on ET-3-induced [Ca2+]i 
increase, strongly suggests that the rise of [Ca2+]i 
stimulated by ET-3 resulted from intracellular Ca z+ 
release rather than Ca 2+ influx from extracellular 
source. 
In fact, the present study shows that ET-3 induces an 
immediate (15-30 s) and dose-responsive effect on IP3 
formation, suggesting that ET-3 stimulates phospho- 
inositide breakdown in EC in a similar manner as does 
ET-1 in VSMC [9]. Since IP3 serves as a second 
messenger for mobilizing Ca 2÷ from intracellular store 
sites [10], the concomitant rapid responses in both IP3 
formation and [Ca2+]i increase by ET-3 indicate that 
the ET-3-induced increase in [Ca2+]i derives mainly 
from intracellular Ca 2÷ mobilization in EC. 
However, the dose-dependency of ET-3 
(10-1°-10 -7 M) on increases in [Ca2+]i and IP3 forma- 
tion does not appear to correspond to the apparent Ka 
values from the binding data. The apparent discrepan- 
cy may be partly accounted for by different cell 
preparations and incubation conditions (temperature, 
time) used for the binding study and measurements of 
[CaZ+h and IP3 formation. Alternatively, the 
ET-3-induced [Ca2+]i ncrease and IP3 formation in EC 
may be a consequence of the activation of the lower- 
affinity ET-3 receptors. Indeed, it has recently been 
reported that there also exist two subpopulations of 
ET-1 receptors in cultured rat glomerular mesangial 
cells and the ET-l-induced IP3 formation, [Ca2+]i in- 
crease and subsequent contraction may be mediated 
through the low-affinity ET-1 receptors [11]. If that is 
the case, the nature of the biological response by the 
higher-affinity ET-3 receptors in EC needs to be 
elucidated. 
Our data are consistent with the contention that 
mobilization of intracellular Ca 2+ is required for the 
production and/or release of endothelium-derived 
vasodilators, such as EDRF and prostacyclin [12]. 
Thus, the presence of specific ET-3 receptors in EC 
strongly suggests that ET-3 plays an important role in 
the regulation of vasodilatation, possibly via receptor- 
mediated release of EDRF and/or prostacyclin from 
EC. The precise interaction between the ET-l-induced 
vasoconstriction and the ET-3-induced vasodilatation 
in the regulation of vascular tonus remains open to 
question. 
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